Amorolfine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
D01AE16
CAS registry number (Chemical Abstracts Service)
0078613-35-1
Chemical Formula
C21-H35-N-O
Molecular Weight
318
Therapeutic Category
Antifungal agent for topical use
Chemical Name
(±)-cis-2,6-Dimetyl-4-[2-metyl-3-(p-tert-pentylphenyl)propyl]morpholine (WHO)
Foreign Names
- Amorolfinum (Latin)
- Amorolfin (German)
- Amorolfine (French)
- Amorolfina (Spanish)
Generic Names
- Amorolfine (OS: BAN, DCF, USAN)
- Ro 14-4767/000 (Roche) (IS)
- Ro 14-4767/002 (Roche) (IS)
- Amorolfine Hydrochloride (OS: BANM, JAN)
- Amorolfine Hydrochloride (PH: BP 2018)
- Amorolfine hydrochloride (PH: Ph. Eur. 9)
Brand Names
- Amofin
Belupo, Croatia (Hrvatska) - Amorolfin-Teva 50 mg/ml
Teva, Hungary - Arivil
Farmal, Croatia (Hrvatska) - Dermoceryl
EMS, Brazil - Fental
Sieger Pharma, Greece - Fungilac
Farmal, Croatia (Hrvatska) - Funtrol
Axxon, Poland; Chanelle Medical, Romania; Polta, Lithuania - Loceryl
Galderma, Argentina; Galderma, Hong Kong; Galderma, India; Galderma, Malaysia; Galderma, Peru; Galderma, Uruguay; Galderma Chile Laboratorios, Chile; Galderma Laboratories, South Africa; Lex ano, Lithuania - Loceryl 5%
Eczacibasi Ilac Pazarlama, Turkey; Galderma, Cyprus - Loceryl 50 mg/ml
Galderma, Hungary - Loceryl Amorolfine
Galderma, Tunisia - Locetar
Galderma, Philippines - Lomytrat
Legrand/OTC, Brazil - Myconail
AFT, New Zealand - Myconolak
Axxon, Poland - Neolaque
Chanelle Medical, Serbia - Razole
Bilim, Turkey - Amocoat
Hwang's, Taiwan - Amofin 5%
Galenpharma, Germany - Amorocutan
Dermapharm, Germany - Amorocutan 50mg/ml
Dermapharm, Austria; Dermapharm, Switzerland - Amorolak
Sun-Farm, Poland - Amorolfin ABECE
Evolan, Sweden - Amorolfin AL 5%
Aliud Pharma, Germany - Amorolfin Apofri
Apofri, Sweden - Amorolfin Heumann
Heumann, Germany - Amorolfin Mylan
Mylan, Sweden - Amorolfin Ratiopharm 5%
Ratiopharm GmbH, Iceland - Amorolfin STADA 5%
Stada Arzneimittel, Germany - Amorolfina Adoh
Adoh, Spain - Amorolfina Ciclum
Ciclum, Portugal - Amorolfina Generis
Generis, Portugal - Amorolfina Isdin
Isdin, Spain - Amorolfina Mylan
Mylan, Spain; Mylan, Portugal - Amorolfina ratiopharm
Ratiopharm, Portugal - Amorolfina Stada
STADA, Spain - Amorolfina Teva
Teva, Spain; Teva Pharma, Portugal - Amorolfina Zentiva
Zentiva, Portugal - Amorolfin-CT 5%
AbZ-Pharma, Germany - Amorolfine 5%
Reckitt Benckiser Healthcare UK, United Kingdom - Amorolfine 5% Actavis
Actavis UK, United Kingdom - Amorolfine 5% Aspire
Aspire Pharma, United Kingdom - Amorolfine 5% Zentiva
Zentiva, United Kingdom - Amorolfine Arrow 5%
Arrow, France - Amorolfine BGR 5%
Biogaran, France - Amorolfine Biogaran Conseil 5 %
Biogaran, France - Amorolfine Chanelle
Chanelle Medical, Hong Kong - Amorolfine Cristers 5%
CristerS, France - Amorolfine EG 5%
EG Labo, France - Amorolfine EG Labo Conseil 5 %
EG Labo, France - Amorolfine Hydrochloride 5%
Stada Arzneimittel, United Kingdom - Amorolfine Mylan 5%
Mylan, France - Amorolfine Mylan Conseil 5 %
Mylan, France - Amorolfine Pierre Fabre
Pierre Fabre, Sweden - Amorolfine Pierre Fabre 5%
Pierre Fabre Dermatologie, France - Amorolfine Ranbaxy 5%
Ranbaxy, France - Amorolfine Sandoz
Sandoz, Taiwan - Amorolfine Sandoz 5%
Sandoz, France - Amorolfine Sandoz Conseil 5 %
Sandoz, France - Amorolfine Teva 5%
Teva Pharma Belgium, Belgium; Teva Santé, France - Amorolfine Urgo 5%
Urgo, France - Amorolfine Zentiva 5%
Sanofi Aventis, France - Amorolfine Zydus 5%
Zydus, France - Amorolfin-Mepha 5%
Mepha Pharma, Switzerland - Amorolfin-ratiopharm 5%
ratiopharm, Germany - Aporyl
Apotex, Australia - Avoza
UBI, Taiwan - Boots Once Weekly Fungal Nail Treatment 5%
The Boots Company, United Kingdom - Care Antifungal 5%
Thornton & Ross, United Kingdom - Chemists' Own Amer-Fine
Arrow Pharmaceuticals, Australia - Clavusimyl 5%
Generics UK, United Kingdom - Curanail
Galderma, Ireland - Curanail 5%
Galderma Benelux, Belgium - Curanel 50mg/ml
Galderma Schweiz, Switzerland - Finail
Orifarm Generics, Denmark; Orifarm Generics, Sweden - Fungilac
Jadran, Bosnia & Herzegowina - Fung-X 50 mg/ml
Axapharm, Switzerland - Laquifun
Panalab, Argentina - Loceryl
Actavis Group, Malta; Galderma, Austria; Galderma, Australia; Galderma, Bahrain; Galderma, Brazil; Galderma, China; Galderma, Czech Republic; Galderma, Ecuador; Galderma, Estonia; Galderma, Greece; Galderma, Ireland; Galderma, Lebanon; Galderma, Lithuania; Galderma, Latvia; Galderma, Mexico; Galderma, Norway; Galderma, New Zealand; Galderma, Poland; Galderma, Singapore; Galderma, Thailand; Galderma, Taiwan; Galderma, Venezuela; Galderma Nordic, Denmark; Galderma Nordic, Sweden; Galderma Nordic AB, Iceland; Laboratoires Galderma, Israel - Loceryl 0,25%
Galderma, Germany - Loceryl 2.5 mg/g
Galderma, Hungary - Loceryl 5%
Galderma, France; Galderma, Luxembourg; Galderma, Slovakia; Galderma Benelux, Belgium; Galderma Nordic AB, Finland; Galderma U.K., United Kingdom - Loceryl Curanail 5%
Galderma U.K., United Kingdom - Locetar
Galderma, Spain; Galderma, Portugal; Galderma Italia, Italy - Micocide A
Atlas Farmc., Argentina; Mediderm, Chile - Myconail
AFT Pharmaceuticals, Australia - Myconxin
Root, Taiwan - Nailcure Sandoz 50mg/ml
Sandoz, Switzerland - Neolaque 50 mg/ml
PharmaSwiss, Hungary - Odenil
Galderma, Spain - Onicoryl
Germed Farmaceutica, Brazil - Pekiron
Shinlin Sinseng, Taiwan - Pekiron 0.5%
Galderma, Japan - Pharmacy Action Antifungal Nail Treatment
Generic Health, Australia - Sanail-Mepha once a week 50mg/ml
Mepha Pharma, Switzerland - Sandoz Nail Repair
Sandoz, Australia - Schollmed once weekly 5%
Reckitt Benckiser Healthcare UK, United Kingdom - Sinibal
Atral, Portugal
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.